Browse
Submit Data
Databases
API
Help

Dataset Information

0 Views

0 Connections

0 Citations

0 Reanalyses

0 Downloads

Omics score: 0

The Cryptococcal Central Nervous System Transcriptome during Human Disease

ABSTRACT: The Cryptococcal Central Nervous System Transcriptome during Human Disease

PROVIDER: PRJNA718309 | ENA |

REPOSITORIES: ENA

ACCESS DATA

Json Xml

Dataset's files

Source:

			Action	DRS
	SRR14095800_1.fastq.gz	Fastqsanger.gz
	SRR14095800_2.fastq.gz	Fastqsanger.gz
	SRR14095801_1.fastq.gz	Fastqsanger.gz
	SRR14095801_2.fastq.gz	Fastqsanger.gz
	SRR14095802_1.fastq.gz	Fastqsanger.gz

Items per page:

1 - 5 of 250

Similar Datasets

Efavirenz Central Nervous System Side Effects

Project description:Efavirenz Central Nervous System Side Effects

| PRJNA354669 | ENA

Prox1 inhibits axon outgrowth during central nervous system development

Project description:Prox1 inhibits axon outgrowth during central nervous system development

| PRJNA666924 | ENA

Iodine I 131 Monoclonal Antibody 3F8 in Treating Patients With Central Nervous System Cancer or Leptomeningeal Cancer

Project description:RATIONALE: Radiolabeled monoclonal antibodies, such as iodine I 131 monoclonal antibody 3F8, can find tumor cells and carry tumor-killing substances to them without harming normal cells. This may be an effective treatment for central nervous system cancer or leptomeningeal metastases. PURPOSE: This phase II trial is studying the side effects and how well iodine I 131 monoclonal antibody 3F8 works in treating patients with central nervous system cancer or leptomeningeal cancer.

| 2037925 | ecrin-mdr-crc

The Cryptococcal Central Nervous System Transcriptome during Human Disease

Project description:The transcriptional responses of cryptococcus during human infection are dynamic and highly dependent on the immediate signals from the environment. We examined the RNA-Seq profiles of Cryptococcus isoalted from human CSF and in comparison with to the same isolate's response to the stresses of artificial CSF and within the rabbit subarachnoid space as well as growth in nutritious media with little or no stress. By comparing these transcriptomes, we have identified regulated genes and categorized them by networks and functional classifications to identify candidate genes essential for yeast survival and as well as those uniformly expressed in CSF across diverse isolates that may be markers for the human disease state.

2021-03-30 | GSE171092 | GEO

Genomic aberrations in primary central nervous system lymphoma (PCNSL)

Project description:Genomic aberrations in primary central nervous system lymphoma (PCNSL). Two-condition experiment, PCNSLs vs. healthy men. Biological replicates: 12 tumors replicates, 13 peripheral blood replicates.

2010-11-13 | E-GEOD-25298 | biostudies-arrayexpress

Genomic profiling combined with gene expression profiling in primary central nervous system lymphoma

Project description:This SuperSeries is composed of the following subset Series: GSE25297: Genome-wide gene expression comparison (primary central nervous system lymphoma (PCNSL) vs normal lymph node) GSE25298: Genomic aberrations in primary central nervous system lymphoma (PCNSL) Refer to individual Series

2010-11-13 | E-GEOD-25299 | biostudies-arrayexpress

Genomic aberrations in primary central nervous system lymphoma (PCNSL)

Project description:Genomic aberrations in primary central nervous system lymphoma (PCNSL).

2010-11-13 | GSE25298 | GEO

GM-CSF in the central nervous system

Project description:The functional outcome of GM-CSF in the central nervous system

| PRJEB27657 | ENA

Engineered T cell therapy for central nervous system injury

Project description:Engineered T cell therapy for central nervous system injury

| PRJNA893390 | ENA

The brain regulatory program predates central nervous system evolution

Project description:The brain regulatory program predates central nervous system evolution